by Web Developer | Mar 11, 2022 | Press Releases, Uncategorized
On December 12, 2021, it has been five years since 2A Pharma was founded. This is a good time to look back and be proud of what we’ve accomplished. Watch the video to see the highlights of the past 5 years.
by Web Developer | Mar 11, 2022 | Press Releases
The virtual 34th International Papillomavirus Conference took place last week, from November 15-19. The conference’s theme this year was: ‘Research and education for HPV elimination’. Jeanettes E-Poster ‘A Candidate Broadly Protective HPV-Vaccine Targeting the L2...
by Web Developer | Mar 11, 2022 | Press Releases
On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg. Jeanette spoke about clinical trials, what they entail, and what her role is in the process of the development of our...
by admin | Jun 25, 2018 | 2018, Funding & Investments, Milestones, Press Releases
2A Pharma is very pleased to announce that it has raised SEK 20 million (USD 2.2M) from existing and new investors. This funding augments the previously raised SEK 27 million (USD 3M) and will enable 2A Pharma to drive its leading vaccine candidate, 2AP01, a...
by admin | Dec 20, 2016 | 2016, Milestones, Press Releases
Medigene AG today announced that it has granted an exclusive, worldwide license for the development and commercialization of its preclinical stage adeno-associated virus-like particles (AAVLPs) technology to 2A Pharma AB. [pdf-embedder...
Recent Comments